Safety and efficacy of Interferon y in Friedreich ataxia, using clinical and paraclinical indicators of disease

The data shared in the Zenodo repository include clinical and instrumental data from a randomized clinical trial open label phase II in Friedreich's Ataxia patients that underwent a 6 months treatment with interferone gamma and 6 months follow-up. Permission to use the data will be given only on direct request, correspondence to Prof. Andrea Martinuzzi ( [e-mail] ).